Naphthalimide-organometallic hybrids as multi-targeted anticancer and luminescent cellular imaging agents

Key Points

• Naphthalimide-organometallic hybrids exhibit significant anticancer properties, suggesting potential treatment options.
• These hybrids also demonstrate effective luminescent properties, facilitating cellular imaging applications.
• Intelligent agent design may enhance the specificity of treatment and sensing in targeted applications.
• Further research is necessary to fully understand their mechanisms and optimize their effectiveness.